Patent · US Active

Anti-CD137 antibodies and uses thereof

US10689454B2 · kind B2 · utility

3Cited by

3References

17Claims

0Family size

Assignee

ALLIGATOR BIOSCIENCE AB · SE

Inventors

Peter Ellmark · Lund, SE
Sara Fritzell · Lund, SE
Christina Furebring · Lund, SE
Jessica Petersson · Lund, SE
Anna Sall · Lund, SE
Karin Enell Smith · Lund, SE
Laura Varas · Lund, SE
Laura Von Schantz · Lund, SE
Niina Veitonmaki · Lund, SE

Key dates

Filing date	Jul 17, 2019
Grant date	Jun 23, 2020
Priority date	—
Expiry date	Jul 17, 2039

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/70596
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to antibodies (and fragments, variants, fusions and derivatives thereof) with binding specificity for domain 2 of human CD137 which are capable of inhibiting the binding of a reference antibody to human CD137. The antibodies and fragments have utility in the treatment of diseases such as cancer. The invention also relates to pharmaceutical compositions, uses, methods and kits comprising such antibodies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.